Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

JAAD Case Rep. 2018 Feb 23;4(3):229-231. doi: 10.1016/j.jdcr.2017.09.028. eCollection 2018 Apr.
No abstract available

Keywords: PD-1, programmed death-1 protein; TEN, toxic epidermal necrolysis; adverse events; immune related; irAEs, immune-related adverse events; lymphoma; nivolumab; programmed death-1 inhibitor; toxic epidermal necrolysis.

Publication types

  • Case Reports